KN
Kanaka Nallamilli Sundara Reddy
About Kanaka Nallamilli Sundara Reddy
Data last updated:
Kanaka Nallamilli Sundara Reddy is a Director at Shreegen Pharma Limited (since 2016) and Director at Symbiosis Feeds India Private Limited (since 2017). The companies operate in Pharma and Agriculture. The 2 current companies with reported revenue have a combined latest revenue of ₹16.47 Cr; the largest is Shreegen Pharma Limited at ₹9.20 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shreegen Pharma Limited U24233TG2012PLC083695 | Director | 30 Sep 2016 | 2012 | ₹9.20 Cr (FY 2023) | Active |
 Symbiosis Feeds India Private Limited U15100AP2017PTC105486 | Director | 23 Mar 2017 | 2017 | ₹7.27 Cr (FY 2022) | Active |
Board colleagues of Kanaka Nallamilli Sundara Reddy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandra Balireddy Kotthapalli | 08330111 | Shreegen Pharma Limited | Additional Director |
| Rajeev Dinesh Srivastava | 07861590 | Shreegen Pharma Limited | Additional Director |
| Rama Mangeswar Reddy Bobbiti | 03468091 | Shreegen Pharma Limited | Managing Director |
| Sishtla Ramakrishnan | 07955919 | Shreegen Pharma Limited | Director |
| Srinivasa Reddy Daka | 05335763 | Shreegen Pharma Limited | Director |
| Venkata Suryanarayana Reddy Chilukuri | Shreegen Pharma Limited | Cfo | |
| Ram Naresh Reddy | 07637787 | Symbiosis Feeds India Private Limited | Director |
| Rambabu Thottala | 02778306 | Symbiosis Feeds India Private Limited | Director |
| Venkata Suryanarayana Reddy Chilukuri | 07637969 | Symbiosis Feeds India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kanaka Nallamilli Sundara Reddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kanaka Nallamilli Sundara Reddy
Kanaka Nallamilli Sundara Reddy currently holds 2 directorships: Shreegen Pharma Limited (Director, since 30 Sep 2016, revenue ₹9.20 Cr (FY 2023)); Symbiosis Feeds India Private Limited (Director, since 23 Mar 2017, revenue ₹7.27 Cr (FY 2022)).
Kanaka Nallamilli Sundara Reddy was first appointed on 30 Sep 2016 as Director at Shreegen Pharma Limited. The most recent appointment on record is 23 Mar 2017 at Symbiosis Feeds India Private Limited.
The 2 current companies of Kanaka Nallamilli Sundara Reddy that report revenue have a combined latest revenue of ₹16.47 Cr: Shreegen Pharma Limited ₹9.20 Cr (FY 2023); Symbiosis Feeds India Private Limited ₹7.27 Cr (FY 2022).
The current boards of Kanaka Nallamilli Sundara Reddy's companies include Chandra Balireddy Kotthapalli (Shreegen Pharma Limited), Rajeev Dinesh Srivastava (Shreegen Pharma Limited), Rama Mangeswar Reddy Bobbiti (Shreegen Pharma Limited), Sishtla Ramakrishnan (Shreegen Pharma Limited), Srinivasa Reddy Daka (Shreegen Pharma Limited), Venkata Suryanarayana Reddy Chilukuri (Shreegen Pharma Limited), among others.